January 17, 2025 at 11:42 ESTDaily Item
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers. The price negotiations for the additional 15 drugs selected Friday will be handled by the incoming Trump administration and almost assure billions of dollars in savings for taxpayers. U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program and say it “fails to address the true challenges facing seniors and Medicare.” Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey.
